Available from: Murdoch D, McTavish D
Pri bolnikih, ki jemljejo semaglutid, bi lahko bilo tveganje za predoziranje z opioidi manje, kar nakazuje, da bi ga lahko uporabljali tudi za zdravljenje odvisnosti od opioidov
In the last few years Hollywood stars, wellness influencers, and the media have brought increased awareness to a class of medications traditionally used in the treatment of diabetes, and now being used for weight loss: glucagon-like peptide 1 (GLP-1) agonists
instead, diagnosis is a process that rules out factors such as learning disabilities and anxiety, which may cause similar symptoms
The most common were gallbladder-related issues (cholecystitis, cholelithiasis) at 2.4%, consistent with other GLP-1 medications
A double-blind, placebo controlled, randomized withdrawal design study (Study 13) was conducted to evaluate maintenance of efficacy based on time to relapse between VYVANSE and placebo in adults aged 18 to 55 (N=267) with moderate to severe BED